Nicole Urban

Nicole Urban

UNVERIFIED PROFILE

Are you Nicole Urban?   Register this Author

Register author
Nicole Urban

Nicole Urban

Publications by authors named "Nicole Urban"

Are you Nicole Urban?   Register this Author

100Publications

1800Reads

43Profile Views

Artifact-free objective-type multicolor total internal reflection fluorescence microscopy with light-emitting diode light sources-Part I.

J Biophotonics 2019 Nov 23;12(11):e201900033. Epub 2019 Jul 23.

Rudolf-Boehm-Institut für Pharmakologie und Toxikologie, Universität Leipzig, Leipzig, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jbio.201900033DOI Listing
November 2019

Identification of aurintricarboxylic acid as a potent allosteric antagonist of P2X1 and P2X3 receptors.

Neuropharmacology 2019 Nov 25;158:107749. Epub 2019 Aug 25.

Molecular Pharmacology, RWTH Aachen University, 52074, Aachen, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neuropharm.2019.107749DOI Listing
November 2019

A (+)-Larixol Congener with High Affinity and Subtype Selectivity toward TRPC6.

ChemMedChem 2018 05 26;13(10):1028-1035. Epub 2018 Apr 26.

Rudolf Boehm Institute for Pharmacology and Toxicology, Leipzig University, Härtelstr. 16-18, 04107, Leipzig, Germany.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cmdc.201800021
Publisher Site
http://dx.doi.org/10.1002/cmdc.201800021DOI Listing
May 2018

TDP-43 self-interaction is modulated by redox-active compounds Auranofin, Chelerythrine and Riluzole.

Sci Rep 2018 02 2;8(1):2248. Epub 2018 Feb 2.

Department for Molecular and Cellular Mechanisms of Neurodegeneration, Paul Flechsig Institute for Brain Research, University of Leipzig, Liebigstraße 19, 04103, Leipzig, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-018-20565-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797228PMC
February 2018

Pharmacological inhibition of focal segmental glomerulosclerosis-related, gain of function mutants of TRPC6 channels by semi-synthetic derivatives of larixol.

Br J Pharmacol 2017 Nov 15;174(22):4099-4122. Epub 2017 Oct 15.

Rudolf-Boehm-Institut für Pharmakologie und Toxikologie, Universität Leipzig, Leipzig, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bph.13977DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5659987PMC
November 2017

A benzothiadiazine derivative and methylprednisolone are novel and selective activators of transient receptor potential canonical 5 (TRPC5) channels.

Cell Calcium 2017 09 2;66:10-18. Epub 2017 Jun 2.

Rudolf-Boehm-Institute of Pharmacology and Toxicology, Leipzig University, Härtelstraße 16-18, 04107 Leipzig, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ceca.2017.05.012DOI Listing
September 2017

Evaluating Serum Markers for Hormone Receptor-Negative Breast Cancer.

PLoS One 2015 13;10(11):e0142911. Epub 2015 Nov 13.

Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, Washington, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0142911PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643893PMC
June 2016

Identification and Validation of Larixyl Acetate as a Potent TRPC6 Inhibitor.

Mol Pharmacol 2016 Jan 23;89(1):197-213. Epub 2015 Oct 23.

Rudolf-Boehm-Institut für Pharmakologie und Toxikologie, Universität Leipzig, Leipzig, Germany (N.U., M.S.); Institut für Pharmazie, Freie Universität Berlin, Berlin, Germany (S.K., J.R.); and The Keenan Research Centre of St. Michael's Hospital, Toronto, Canada (L.W., W.M.K.)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/mol.115.100792DOI Listing
January 2016

Identification of novel candidate plasma metabolite biomarkers for distinguishing serous ovarian carcinoma and benign serous ovarian tumors.

Gynecol Oncol 2016 Jan 30;140(1):138-44. Epub 2015 Oct 30.

Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2015.10.021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5310763PMC
January 2016

Preclinical safety and efficacy studies with an affinity-enhanced epithelial junction opener and PEGylated liposomal doxorubicin.

Mol Ther Methods Clin Dev 2015 11;2:15005. Epub 2015 Mar 11.

Division of Medical Genetics, University of Washington , Seattle, Washington, USA ; Department of Pathology, University of Washington , Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/mtm.2015.5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445001PMC
June 2015

Leveraging biospecimen resources for discovery or validation of markers for early cancer detection.

J Natl Cancer Inst 2015 Apr 16;107(4). Epub 2015 Feb 16.

: Division of Cancer Control and Population Sciences (SDS, DMC, LEM, VPDR, MJK), Division of Cancer Prevention (SuS, BSK), and Division of Cancer Treatment and Diagnosis (LMM), National Cancer Institute, Bethesda, MD; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA (GLA, NU); Department of Medicine, University of North Carolina, Chapel Hill, NC (JAB, DFR); Department of Radiation Oncology, Johns Hopkins Medicine, Baltimore, MD (CDB); Center for Prostate Disease Research, Department of Defense, Rockville, MD (JC); Mount Sinai Hospital, Toronto, Ontario, Canada (EPD); Center for Health Research, Kaiser Permanente, Northwest, Portland, OR (KABG); Division of Biostatistics and Epidemiology, University of Massachusetts, Amherst, MA (SEH); Division of Research, Kaiser Permanente, Oakland, CA (LHK); Group Health Research Institute, Seattle, WA (EBL); American Society of Clinical Oncology, Alexandria, VA (RLS); Genomic Health, Inc., Redwood City, CA (StS); Biostatistics Center, Massachusetts General Hospital, Boston, MA (SJS); Office of Public Health Genomics, Centers for Disease Control and Prevention, Atlanta, GA (MJK).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4342676PMC
April 2015

Natural compounds with P2X7 receptor-modulating properties.

Purinergic Signal 2014 27;10(2):313-26. Epub 2013 Oct 27.

Rudolf-Boehm-Institute of Pharmacology and Toxicology, University of Leipzig, Haertelstr. 16-18, 04107, Leipzig, Germany,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11302-013-9392-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4040168PMC
January 2015

A small molecule restores function to TRPML1 mutant isoforms responsible for mucolipidosis type IV.

Nat Commun 2014 Aug 14;5:4681. Epub 2014 Aug 14.

1] Department of Pharmacy-Center for Drug Research and Center for Integrated Protein Science Munich (CIPSM), Ludwig-Maximilians-Universität München, Munchen 81377, Germany [2].

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncomms5681DOI Listing
August 2014

JAK2 expression is associated with tumor-infiltrating lymphocytes and improved breast cancer outcomes: implications for evaluating JAK2 inhibitors.

Cancer Immunol Res 2014 Apr 15;2(4):301-6. Epub 2014 Jan 15.

Authors' Affiliations: Center for Computational Biology and Bioinformatics, Department of Electrical Engineering, Columbia University, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-13-0189DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4001121PMC
April 2014

The phenothiazine-class antipsychotic drugs prochlorperazine and trifluoperazine are potent allosteric modulators of the human P2X7 receptor.

Neuropharmacology 2013 Dec 14;75:365-79. Epub 2013 Aug 14.

Rudolf-Boehm-Institute of Pharmacology and Toxicology, Medical Faculty, University of Leipzig, Härtelstrasse 16-18, 04107 Leipzig, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neuropharm.2013.07.027DOI Listing
December 2013

Apomorphine is a bimodal modulator of TRPA1 channels.

Mol Pharmacol 2013 Feb 6;83(2):542-51. Epub 2012 Dec 6.

Rudolf-Boehm Institute of Pharmacology and Toxicology, University of Leipzig, Leipzig, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/mol.112.081976DOI Listing
February 2013

Interpretation of single and serial measures of HE4 and CA125 in asymptomatic women at high risk for ovarian cancer.

Cancer Epidemiol Biomarkers Prev 2012 Nov 7;21(11):2087-94. Epub 2012 Sep 7.

Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, M2-B230, P.O. Box 19024, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://cebp.aacrjournals.org/cgi/doi/10.1158/1055-9965.EPI-1
Publisher Site
http://dx.doi.org/10.1158/1055-9965.EPI-12-0616DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493821PMC
November 2012

Prophylactic oophorectomy rates in relation to a guideline update on referral to genetic counseling.

Gynecol Oncol 2012 Aug 4;126(2):229-35. Epub 2012 May 4.

Group Health Research Institute, 1730 Minor Ave, Suite 1600, Seattle, WA 98101-1448, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2012.04.046DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3383401PMC
August 2012

Novel pharmacological TRPC inhibitors block hypoxia-induced vasoconstriction.

Cell Calcium 2012 Feb 24;51(2):194-206. Epub 2012 Jan 24.

Rudolf-Boehm-Institute of Pharmacology and Toxicology, University of Leipzig, Härtelstrasse 16-18, Leipzig, Germany.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01434160120000
Publisher Site
http://dx.doi.org/10.1016/j.ceca.2012.01.001DOI Listing
February 2012

Early diagnosis of ovarian carcinoma: is a solution in sight?

Radiology 2011 May;259(2):329-45

Department of Radiology, Bio-X Program, Stanford University School of Medicine, 318 Campus Dr, Room E150, Stanford, CA 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.11090563DOI Listing
May 2011

Clemastine potentiates the human P2X7 receptor by sensitizing it to lower ATP concentrations.

J Biol Chem 2011 Apr 24;286(13):11067-81. Epub 2011 Jan 24.

Rudolf Boehm Institute of Pharmacology and Toxicology, University of Leipzig, Leipzig, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M110.198879DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3064161PMC
April 2011

Quantitative comparison of erythropoietin receptor levels in the epithelial versus endothelial fractions of primary breast tumors.

Anticancer Res 2011 Apr;31(4):1189-95

Department of Medicine,University of Washington, Seattle, WA 98195-8056, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401416PMC
April 2011

Influence of the pre-operative time in upright sitting position and the needle type on the incidence of post-dural puncture headache (PDPH) in patients receiving a spinal saddle block for anorectal surgery.

Int J Colorectal Dis 2011 Jan 22;26(1):97-102. Epub 2010 Jul 22.

Department of Anaesthesiology and Surgical Intensive Care Medicine, University Medical Centre Mannheim, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00384-010-1012-8DOI Listing
January 2011

Activation of the MEK-S6 pathway in high-grade ovarian cancers.

Appl Immunohistochem Mol Morphol 2010 Dec;18(6):499-508

Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAI.0b013e3181e53e1cDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2989426PMC
December 2010

Breast cancer genomics: normal tissue and cancer markers.

Ann N Y Acad Sci 2010 Oct;1210:78-85

Molecular Diagnostics Program, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1749-6632.2010.05803.xDOI Listing
October 2010

Use of a single-chain antibody library for ovarian cancer biomarker discovery.

Mol Cell Proteomics 2010 Jul 13;9(7):1449-60. Epub 2010 May 13.

Molecular Diagnostics Program, Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/mcp.M900496-MCP200DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2938096PMC
July 2010

Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer.

Gynecol Oncol 2010 Mar 28;116(3):378-83. Epub 2009 Nov 28.

Molecular Diagnostics Program, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2009.10.087DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2822097PMC
March 2010

DNA methylation profiles of ovarian epithelial carcinoma tumors and cell lines.

PLoS One 2010 Feb 22;5(2):e9359. Epub 2010 Feb 22.

Department of Biochemistry and Molecular Biology, University of Southern California, Los Angeles, California, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0009359PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2825254PMC
February 2010

Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study.

J Natl Cancer Inst 2010 Jan 30;102(1):26-38. Epub 2009 Dec 30.

Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, PO Box 19024, M3-A410, Seattle, WA 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djp438DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2802285PMC
January 2010

Antifouling surface layers for improved signal-to-noise of particle-based immunoassays.

Langmuir 2009 Dec;25(23):13510-5

Biomarker Research and Development Centre, Level 5 East, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St. Lucia, QLD 4072, Australia.

View Article

Download full-text PDF

Source
http://pubs.acs.org/doi/abs/10.1021/la903148n
Publisher Site
http://dx.doi.org/10.1021/la903148nDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2891774PMC
December 2009

Evaluating erythropoietin-associated tumor progression using archival tissues from a phase III clinical trial.

Stem Cells 2009 Sep;27(9):2353-61

Department of Medicine/Hematology and the Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, Washington 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/stem.156DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2911228PMC
September 2009

The temporal stability of the Symptom Index among women at high-risk for ovarian cancer.

Gynecol Oncol 2009 Aug 7;114(2):225-30. Epub 2009 May 7.

Molecular Diagnostics Program, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2009.03.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2736546PMC
August 2009

DNA hypermethylation, Her-2/neu overexpression and p53 mutations in ovarian carcinoma.

Gynecol Oncol 2008 Nov 30;111(2):320-9. Epub 2008 Aug 30.

Department of Pathology, School of Medicine, University of Washington, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2008.07.036DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2642648PMC
November 2008

Combining a symptoms index with CA 125 to improve detection of ovarian cancer.

Cancer 2008 Aug;113(3):484-9

Molecular Diagnostics Program, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.23577DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2734274PMC
August 2008

Potential and limitations in early diagnosis of ovarian cancer.

Adv Exp Med Biol 2008 ;622:3-14

Higuchi Biosciences Center, University of Kansas, Lawrence, KS, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-0-387-68969-2_1DOI Listing
July 2008

Use of cancer-specific yeast-secreted in vivo biotinylated recombinant antibodies for serum biomarker discovery.

J Transl Med 2008 Jul 24;6:41. Epub 2008 Jul 24.

Center for Research on Early Detection and Cure of Ovarian Cancer, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1479-5876-6-41DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2503970PMC
July 2008

Effects of alpha/beta-androstenediol immune regulating hormones on bone remodeling and apoptosis in osteoblasts.

J Steroid Biochem Mol Biol 2008 Jun 25;110(3-5):223-9. Epub 2008 Apr 25.

Department of Orthopaedic Surgery, Virginia Commonwealth University School of Medicine, Richmond, VA 23298-0694, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jsbmb.2008.04.005DOI Listing
June 2008

Secondary BRCA1 mutations in BRCA1-mutated ovarian carcinomas with platinum resistance.

Cancer Res 2008 Apr;68(8):2581-6

Department of Obstetrics and Gynecology, University of Washington, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-08-0088DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2674369PMC
April 2008

Use of high density antibody arrays to validate and discover cancer serum biomarkers.

Mol Oncol 2007 Dec 30;1(3):313-20. Epub 2007 Aug 30.

Molecular Diagnostics Program, Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2007.08.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2671017PMC
December 2007

CA125 in ovarian cancer.

Biomark Med 2007 Dec;1(4):513-23

Center for Research on Early Detection & Cure of Ovarian Cancer School of Medicine, University of Pennsylvania Biomedical Research Building (BRB) II/III, Suite 1355 421 Curie Blvd, PA 19104-6080, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/17520363.1.4.513DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2872496PMC
December 2007

Development and in vitro validation of anti-mesothelin biobodies that prevent CA125/Mesothelin-dependent cell attachment.

Cancer Lett 2007 Oct 7;255(2):263-74. Epub 2007 Jun 7.

Molecular Diagnositics Program, Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2007.04.012DOI Listing
October 2007

Changes in cancer worry associated with participation in ovarian cancer screening.

Psychooncology 2007 Sep;16(9):814-20

Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pon.1151DOI Listing
September 2007

Evaluation of the novel serum markers B7-H4, Spondin 2, and DcR3 for diagnosis and early detection of ovarian cancer.

Gynecol Oncol 2007 Jul 8;106(1):112-8. Epub 2007 May 8.

diaDexus, Inc., 343 Oyster Point Blvd., South San Francisco, CA 94080, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2007.03.007DOI Listing
July 2007

Expression of RANKL in osteolytic membranes: association with fibroblastic cell markers.

J Bone Joint Surg Am 2007 Apr;89(4):841-8

Department of Biochemistry, Orthopaedic Research Laboratory, Virginia Commonwealth University School of Medicine, Richmond, VA 23298-0614, USA.

View Article

Download full-text PDF

Source
http://jbjs.org/cgi/doi/10.2106/JBJS.F.00655
Publisher Site
http://dx.doi.org/10.2106/JBJS.F.00655DOI Listing
April 2007

Development of a CA125-mesothelin cell adhesion assay as a screening tool for biologics discovery.

Cancer Lett 2007 Mar 4;247(1):130-6. Epub 2006 May 4.

Molecular Diagnostics Program, Public Health Sciences, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2006.03.029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2734268PMC
March 2007

Comparing adaptive and non-adaptive algorithms for cancer early detection with novel biomarkers.

Cancer Biomark 2006 ;2(3-4):151-62

Fred Hutchinson Cancer Research Center, Seattle, WA 90109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/cbm-2006-23-407DOI Listing
February 2007

Development of an ovarian cancer symptom index: possibilities for earlier detection.

Cancer 2007 Jan;109(2):221-7

Department of Obstetrics and Gynecology, University of Washington School of Medicine, Seattle, Washington 98196-6460, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.22371DOI Listing
January 2007

Method for generation of in vivo biotinylated recombinant antibodies by yeast mating.

J Immunol Methods 2006 Dec 30;317(1-2):132-43. Epub 2006 Oct 30.

Translational Outcomes Research Group, Molecular Diagnostics Program, Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jim.2006.10.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1784068PMC
December 2006

Current and future developments in screening for ovarian cancer.

Womens Health (Lond) 2006 Sep;2(5):733-42

Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, M2-B230 Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/17455057.2.5.733DOI Listing
September 2006

Assertiveness with physicians is related to women's perceived roles in the medical encounter.

Women Health 2005 ;42(2):15-33

Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1300/j013v42n02_02DOI Listing
June 2006

Bead-based ELISA for validation of ovarian cancer early detection markers.

Clin Cancer Res 2006 Apr;12(7 Pt 1):2117-24

Translational Outcomes Research Laboratory, Fred Hutchinson Cancer Research Center, Public Health Sciences, and Harborview Medical Center, University of Washington, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-05-2007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2734269PMC
April 2006

Antibody immunity to the p53 oncogenic protein is a prognostic indicator in ovarian cancer.

J Clin Oncol 2006 Feb 3;24(5):762-8. Epub 2006 Jan 3.

Center for Translational Medicine in Women's Health, Tumor Vaccine Group, University of Washington, and the Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.03.2813DOI Listing
February 2006

Regulation of smooth muscle calcium sensitivity: KCl as a calcium-sensitizing stimulus.

Am J Physiol Cell Physiol 2005 Apr;288(4):C769-83

Virginia Commonwealth Univ., School of Medicine, Dept. of Biochemistry, 1101 E. Marshall St., PO Box 980614, Richmond, VA 23298-0614, USA.

View Article

Download full-text PDF

Source
http://www.physiology.org/doi/10.1152/ajpcell.00529.2004
Publisher Site
http://dx.doi.org/10.1152/ajpcell.00529.2004DOI Listing
April 2005

Using a population-based cancer registry for recruitment of newly diagnosed patients with ovarian cancer.

Am J Clin Oncol 2005 Feb;28(1):17-20

Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.coc.0000138967.62532.2eDOI Listing
February 2005

Examining the cost-effectiveness of cancer screening promotion.

Cancer 2004 Sep;101(5 Suppl):1229-38

Cancer Prevention Program, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98102-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.20511DOI Listing
September 2004

Worry about ovarian cancer risk and use of screening by high-risk women: how you recruit affects what you find.

Am J Med Genet A 2004 Aug;129A(2):130-5

Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajmg.a.30247DOI Listing
August 2004

Compliance of average- and intermediate-risk women to semiannual ovarian cancer screening.

Cancer Epidemiol Biomarkers Prev 2004 Apr;13(4):600-6

Swedish Hospital and Medical Center, 1101 Madison Street, Suite 1500, Seattle, WA 98104, USA.

View Article

Download full-text PDF

Source
April 2004